Company Filing History:
1 out of 1,745 
1 out of 157 
1 out of 116 
Years Active: 2024
Title: The Innovative Contributions of Vincent Larrue
Introduction
Vincent Larrue is a notable inventor based in Toulouse, France. He has made significant contributions to the field of medical research, particularly in understanding and addressing ischemic conditions. His work focuses on preserving vascular endothelial cell barrier integrity, which is crucial for patient recovery following ischemic events.
Latest Patents
Vincent Larrue holds a patent titled "Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity." This invention addresses the critical issue of ischemia, a condition characterized by reduced blood flow and oxygen to an organ. The patent highlights the importance of re-establishing blood flow and oxygenation after an ischemic episode to limit irreversible damage. Larrue's research demonstrates that genetic inhibition of PI3K-C2β can reduce cerebral infarction in two ischemia/reperfusion models and improve neurological outcomes. This genetic inhibition stabilizes the blood-brain barrier after ischemic stroke and reduces inflammation, providing a promising method for preserving vascular endothelial cell barrier integrity in patients.
Career Highlights
Throughout his career, Vincent Larrue has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paul Sabatier Toulouse III. His research has contributed to advancements in medical science, particularly in the treatment of ischemic conditions.
Collaborations
Vincent Larrue has collaborated with notable colleagues, including Marie-Pierre Gratacap and Jean Darcourt. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Vincent Larrue's work exemplifies the impact of innovative research on medical science. His patent on PI3KC2B inhibitors represents a significant advancement in preserving vascular endothelial cell barrier integrity, offering hope for improved patient outcomes following ischemic events.